These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 15908516

  • 1. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R, Krausz E, Helenius H, Hietanen S.
    Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
    [Abstract] [Full Text] [Related]

  • 2. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R, Krausz E, Ruotsalainen P, Helenius H, Hietanen S.
    Cancer Res; 2002 Dec 15; 62(24):7364-71. PubMed ID: 12499281
    [Abstract] [Full Text] [Related]

  • 3. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D.
    Int J Oncol; 2006 Sep 15; 29(3):541-8. PubMed ID: 16865269
    [Abstract] [Full Text] [Related]

  • 4. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
    Yamato K, Fen J, Kobuchi H, Nasu Y, Yamada T, Nishihara T, Ikeda Y, Kizaki M, Yoshinouchi M.
    Cancer Gene Ther; 2006 Mar 15; 13(3):234-41. PubMed ID: 16138119
    [Abstract] [Full Text] [Related]

  • 5. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY.
    Reprod Sci; 2007 Jan 15; 14(1):20-8. PubMed ID: 17636212
    [Abstract] [Full Text] [Related]

  • 6. Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists.
    Koivusalo R, Mialon A, Pitkänen H, Westermarck J, Hietanen S.
    Cancer Res; 2006 Dec 15; 66(24):11817-24. PubMed ID: 17178878
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
    Gu W, Putral L, Hengst K, Minto K, Saunders NA, Leggatt G, McMillan NA.
    Cancer Gene Ther; 2006 Nov 15; 13(11):1023-32. PubMed ID: 16810314
    [Abstract] [Full Text] [Related]

  • 13. [Effect of small interference RNA on E6, E7 mRNA of human papillomavirus type-18 in cervical cancer cells].
    Wang P, Cui ZM, Luo B, Lin P.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Mar 15; 41(3):190-3. PubMed ID: 16640887
    [Abstract] [Full Text] [Related]

  • 14. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.
    Apoptosis; 2008 Feb 15; 13(2):273-81. PubMed ID: 18060502
    [Abstract] [Full Text] [Related]

  • 15. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S, Hougardy BM, Meersma GJ, Schaap B, de Vries EG, van der Zee AG, de Jong S.
    Mol Pharmacol; 2012 May 15; 81(5):701-9. PubMed ID: 22328720
    [Abstract] [Full Text] [Related]

  • 16. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES.
    Gynecol Oncol; 2001 Feb 15; 80(2):168-75. PubMed ID: 11161855
    [Abstract] [Full Text] [Related]

  • 17. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki].
    Niu XY, Peng ZL, Wang H.
    Ai Zheng; 2004 Nov 15; 23(11):1257-62. PubMed ID: 15522169
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein.
    Vogt M, Butz K, Dymalla S, Semzow J, Hoppe-Seyler F.
    Oncogene; 2006 Jul 06; 25(29):4009-15. PubMed ID: 16462759
    [Abstract] [Full Text] [Related]

  • 19. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F.
    Oncogene; 1999 Apr 08; 18(14):2381-6. PubMed ID: 10327059
    [Abstract] [Full Text] [Related]

  • 20. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D.
    Gynecol Oncol; 2007 Aug 08; 106(2):299-304. PubMed ID: 17586029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.